Skip to main content

Find Clinical Trials

Home
Conditions
beta-Thalassemia

Clinical trial condition

beta-Thalassemia

Explore clinical trials studying beta-Thalassemia. Study availability and eligibility vary by location and protocol.

184 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

beta-Thalassemia trial results

Completed

Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in Thailand

NCT01609595

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: Mahidol University Thalassemia Research Centre Nakhonpathom, Thailand

View Trial Details

Completed

Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major

NCT00336362

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: George Papanicolaou Hospital Thessaloniki, Greece

View Trial Details

Completed

Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major

NCT01752153

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: Department of Immunology, School of Medicine, Shiraz University of Medical Sciences Shiraz, Fars, Iran

View Trial Details

Completed

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

NCT00061750

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
Locations: Children's Hospital of Los Angeles Los Angeles, California, United States

Children's Hospital Oakland Oakland, California, United States

Stanford Hospital Stanford, California, United States

Children's Memorial Hospital Chicago, Illinois, United States

View Trial Details

Completed

Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major

NCT00480506

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Tehran University of Medical Sciences Tehran, Iran

View Trial Details

Completed

Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload

NCT01039636

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +14 more
Locations: Children's Hospital of Oakland Oakland, California, United States

Children's Hospital of Boston Boston, Massachusetts, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

Royal Adelaide Hospital Adelaide, Australia

View Trial Details

Completed

Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)

NCT00171301

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +14 more
Locations: Novartis Investigative Site Cairo, Egypt

Novartis Investigative Site Beirut, Lebanon

Novartis Investigative Site Muscat, Oman

Novartis Investigative Site Riyadh, Saudi Arabia

View Trial Details

Completed

Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study

NCT01033747

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations: Novartis Investigative Site Cagliari, Italy

Novartis Investigative Site Genova, Italy

Novartis Investigative Site Milan, Italy

Novartis Investigative Site Torino, Italy

View Trial Details

Completed

Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia

NCT00790127

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: Chronic Care Center Beirut, Lebanon

Siriraj Hospital Bangkok, Bangkoknoin District, Thailand

View Trial Details

Completed

Efficacy Study of the Use of Sequential DFP-DFO Versus DFP

NCT00733811

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations: Ao V. Cervello Palermo, Italy

View Trial Details